Executives On The Move: Gamida Cell Decides On Regulatory Appointment, Twist Bio Announces A Promotion And A VP Leaves Sanofi Genzyme For Krystal Biotech
Executive Summary
Cellular and immune therapeutics company Gamida Cell has a new chief regulatory and quality officer and the SVP, R&D at Twist Biosciences steps higher to the chief operating officer position. At Sanofi Genzyme a genetic diseases VP leaves to become chief commercial officer at Krystal Biotech.